TipRanks
First Tracks Biotherapeutics Inc (TRAX)
NASDAQ:TRAX
US Market
TRAX
First Tracks Biotherapeutics Inc
RESEARCH TOOLSreports
Want to see TRAX full AI Analyst Report?

First Tracks Biotherapeutics Inc (TRAX) Income Statement

44 Followers

First Tracks Biotherapeutics Inc Income Statement

Last quarter (Q2 2026), First Tracks Biotherapeutics Inc's total revenue was $0.00, a decrease of ― from previous quarter. In Q2, First Tracks Biotherapeutics Inc's net income was $-33.37M. See First Tracks Biotherapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -139.61M$ -152.34M$ 0.00
Operating Expenses
$ 39.39M$ 28.76M$ 118.46M
Depreciation and Amortization
$ 559.00K$ 2.40M$ 2.38M
EBITDA
$ -178.45M$ -178.70M$ -116.08M
Operating Income
$ -179.01M$ -181.10M$ -118.46M
Other Income/Expenses
$ 12.92M$ 17.40M$ 12.31M
Pretax Income
$ -166.09M$ -163.71M$ -106.15M
Net Income
$ -166.09M$ -163.71M$ -106.15M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ -3.05
Diluted EPS
$ 0.00$ 0.00$ -3.05
Weighted Average Shares Outstanding
 34.75M 34.75M 34.75M
Weighted Average Shares Outstanding (Diluted)
 34.75M 34.75M 34.75M
Currency in USD

First Tracks Biotherapeutics Inc Earnings and Revenue History